{
  "Q0": "BRCA1/2 and PALB2 genetic testing",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4.1": "Yes",
  "Q4.1.1": "NCCN",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9.1": "Yes",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Yes",
  "Q12": "Yes",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14.1": "81162, 81163, 81164, 81165, 81166, 81167, 81307",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "The policy requires that genetic testing be performed in a setting with suitably trained healthcare providers who can provide appropriate pre- and post-test counseling, and that has access to a CLIA-licensed laboratory offering comprehensive variant analysis. The patient should receive genetic counseling before and after testing as specified in the policy guidelines.",
  "match": true
}